Register for the 2024 Personnel Placement Service (PPS) to request an interview.

Details

Posted: 18-Nov-24

Location: Santa Monica, California

Type: Fellowship

Categories:

Pharmacy

Job Setting:

Pharmaceutical Science/Industry

Dear Prospective Candidate,

Kite Pharma, in collaboration with USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, are proud to offer a 12-month US Medical Affairs Fellowship program based in Santa Monica, California. The fellow will be an integral part of the US Medical Affairs team and will create and ensure implementation of strategy for Medical Affairs within the region of United States.

This US Medical Fellow will have the unique opportunity to:

• Help create and implement 2026 Plan of Action (POA) for US Medical
• Support US Medical Director on implementation of key program initiatives
• Participate in cross-functional projects to create internal and external deliverables
• Contribute to strategic activities such as advisory boards, medical education, and evidence generation
• Identify, develop, and execute trainings to increase scientific knowledge and skill development
• Support product launches
• Work on special projects as needed, which will further strategic imperatives
• Collaborate with other departments at Kite (Scientific Communications & Medical Information, Global Medical Affairs Strategy, US Commercial and others) to learn the value that US Medical Affairs bring to the broader organization.

Fellowship Goal:

To provide an opportunity for the fellow to learn the skills necessary for a successful career in the pharmaceutical industry with an emphasis in US Medical Affairs. 

Eligibility Requirement:

To be admitted to the USC-Kite Pharmaceutical Industry Fellowship Program, the candidate must have:

• PharmD, MD, or PhD in applicable field from an accredited university within 5 years of starting the fellowship.
• Good oral and written communication skills, ethics, professionalism, leadership, and an interest in the biopharmaceutical industry
• Minimum GPA of 3.0

Application Requirements

Please apply through the USC application portal found on this page to be considered for this position: https://mann.usc.edu/program/fellowship-programs/admissions/

Applications submitted through PPS will only be used to contact final-round candidates for interviews at ASHP Midyear Meeting.

Please submit your documents in the following format and naming convention:

CV

When submitting documents, please submit as a PDF file and use the following naming conventions:

• Last name_First name_CV.pdf

Letter of Intent

When submitting documents, please submit as a PDF file and use the following naming conventions:

• Last name_First name_LOI_Program of Interest.pdf

Interview Requests: Interviews are limited and will be scheduled on a rolling basis. For early consideration, please submit your application, including your CV and a letter of intent, by November 30, 2024 and at the following link:

https://mann.usc.edu/program/fellowship-programs/admissions/

About Kite:

At Kite, we are focused on the cure. Our singular focus is on cell therapy — the use of genetically modified immune cells programmed to target tumors — which we believe has the potential to change the way cancer is treated.

Through our focused efforts and important industry and academic partnerships we have been able to advance our industry-leading pipeline of chimeric antigen receptor (CAR) and T cell receptor (TCR) product candidates with the goal of treating both hematological cancers and solid tumors.

Founded in 2009 as a pioneer in cell therapy research, Kite’s leadership position in the immuno-oncology space was solidified with our research and development agreement with the National Cancer Institute in 2012 and when our commercial manufacturing site opened in El Segundo in 2016. Since our acquisition by biopharma leader Gilead Sciences in October 2017, our combined strength has accelerated the advancement of our pipeline, including the launch of YESCARTA® (axicabtagene ciloleucel) and TECARTUS® (brexucabtagene autoleucel), and has expanded the impact of our strategic partnerships.

As an independent operating company since 2019, we prioritize innovative R&D with the full resources, capabilities, and trust of Gilead. As a vital part of Gilead — a founding member of the Foundation for the NIH’s Partnership for Accelerating Cancer Therapies — we are devoted to advancing the understanding of cell therapy as a transformational treatment option for cancer. The combined strength of Kite and Gilead allows us to remain innovative, agile, and ambitious in our mission to keep improving the lives of people with all types of cancer.

About USC

The University of Southern California is one of the world’s leading private research universities. An anchor institution in Los Angeles, a global center for arts, technology and international trade, USC enrolls more international students than any other U.S. university and offers extensive opportunities for internships and study abroad. With a strong tradition of integrating liberal and professional education, USC fosters a vibrant culture of public service and encourages students to cross academic as well as geographic boundaries in their pursuit of knowledge.

Connections working at USC